4-(Piperidin-4-yl)pyridine hydrochloride

Catalog No.: 
ACCPOI123
CAS No.: 
196191-99-8
Molecular Formula: 
C10H15ClN2
Molecular Weight: 
198.70
4-(Piperidin-4-yl)pyridine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$98.00In stockInquiry
1g97%$277.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Piperidin-4-yl)pyridine hydrochloride
IUPAC Name4-(piperidin-4-yl)pyridine hydrochloride
MDL No.MFCD30489156
Molecular FormulaC10H15ClN2
Molecular Weight198.70
SMILES[H]Cl.C1(C2CCNCC2)=CC=NC=C1
InChI KeySDFWEWJBZBSUSY-UHFFFAOYSA-N
Synonym4-(Piperidin-4-yl)pyridine hydrochloride | 196191-99-8 | SB41717 | 4-(Piperidin-4-yl)pyridinehydrochloride | 4-(PIPERIDIN-4-YL)PYRIDINE HCL | CS-0163660 | F19968
CAS No.196191-99-8
PubChem CID127255847

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCPOI123 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8In Stock
  6. Then
  7. ACCPOI123 route product structure diagram
    ACCPOI123196191-99-8In Stock
Inquiry

2. ACCPOI123 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCPOI123 route product structure diagram
    ACCPOI123196191-99-8In Stock
Inquiry

3. ACCPOI123 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCPOI123 route product structure diagram
    ACCPOI123196191-99-8In Stock
Inquiry

Comments (0)